Preparing patients for drug refractive cycloplegia


  • E.A. Slabtsova University of Latvia, Riga, Latvia



refraction, drug cycloplegia, M-cholinolytics


One of the most important procedures in the ophthalmologist’s work is to determine the patient’s refraction. This procedure is necessary for patients of any age, because it helps to obtain information about whether the patient has refractive errors, whether they can become an obstacle to the normal formation of visual activity and binocular vision in preschool children, whether refractive errors are the cause of complaints of decreased vision and loss of visual performance (asthenopia) in older patients. The correct determination of static refraction, when the patient’s accommodation is completely relaxed, is not only of great importance at the time of deciding whether to prescribe optical correction — the obtained values are the basis for the clinical prescription itself. The paper presents modern methods for determining refraction, identifies indications for drug refractive cycloplegia, shows mydriatic and cycloplegic activity of M-cholinolytics, provides a comparative evaluation of different cycloplegic agents, recommended schemes of drug refractive cycloplegia.


Elliott D.B. Clinical Procedures in Primary Eye Care. 5th ed. London: Elsevier Health Sciences, 2020.

Heus P., Verbeek J.H., Tikka C. Optical correction of refractive error for preventing and treating eye symptoms in computer ­users. Cochrane Database of Systematic Reviews. 2018. № 4. Article № CD009877.

Schnell P.H., Taub M.B., Duckman R.H. Visual Development, Diagnosis, and Treatment of the Pediatric Patient. 2nd ed. Philadelphia: Wolters Kluwer Health, 2019.

Yanoff M. Advances in Ophthalmology and Optometry. Vol. 4. 1st ed. Philadelphia: Elsiever Health Sciences, 2019.

Elliott D.B. What is the appropriate gold standard test for refractive error? Ophthalmic & Physiological Optics. 2017. № 37. Р. 115-117.

Otero C., Aldaba M., Pujol J. Clinical evaluation of an automa­ted subjective refraction method implemented in a computer-controlled motorized phoropter. Journal of Optometry. 2019. № 12(2). Р. 74-83.

Vasudevan B., Ciuffreda K.J., Meehan K., Grk D., Cox M. Comparison of objective refraction in darkness to cycloplegic refraction: a pilot study. Clinical and Experimental Optometry. 2016. № 99(2). Р. 168-172.

Khandpur R.S. Compendium of Biomedical Instrumentation. Vol. 3. Hoboken: Wiley-Blackwell, 2020.

Keirl A., Christie C. Clinical Optics and Refraction: A Guide for Optometrists, Contact Lens Opticians and Dispensing Opticians. London: Butterworth-Heinemann Ltd, 2007.

Bhootra A.K. Clinical Refraction Guide. 2nd ed. New Delhi: Jaypee Brothers Medical Publishers, 2019.

Anderson H.A., Ravikumar A., Benoit J.S., Marsack J.D. Impact of Pupil Diameter on Objective Refraction Determination and Predicted Visual Acuity. Translational Vision Science & Technology. 2019. № 8(6). Article № 32.

Yazdani N., Sadeghi R., Momeni-Moghaddam H., Zarif­mahmoudi L., Ehsaei A. Comparison of cyclopentolate versus tropicamide cycloplegia: A systematic review and meta-analysis. Journal of Optometry. 2018. № 11(3). Р. 135-143.

AOA Evidence-Based Optometry Guideline Development Group. Evidence-Based Clinical Practice Guideline. Comprehensive Pediatric Eye and Vision Examination. St. Louis: American Optometric Association, 2017.

Ershova R.V., Brzheskiy V.V., Sokolov V.O., Kravchenko E.A. Express-cycloplegia in children with myopia. Objectification of choice. Russian Ophthalmology of Children. 2016. № 2. Р. 30-37.

Tasman W., Jaeger E.A. Duane’s Ophthalmology. Philadelphia: Lippincott Williams & Wilkins, 2013.

Millodot M. Dictionary of Optometry and Vision Science. 8th ed. London: Elsevier Health Sciences, 2017.

Bui-Quoc E., Guilmin-Crepon S., Tinguely S., Lavallee G., Busquet G., Angot M., Vera L. Comparison of Refraction With or Without Cycloplegia Using Retinomax® or Plusoptix® Devices. French Journal of Ophthalmology. 2017. № 40(3). Р. 209-214.

Stringer J.L. Basic Concepts in Pharmacology: What You Need to Know for Each Drug Class. 5th ed. Ohio: McGraw-Hill Education, 2017.

Purviņš I., Purviņa S. Praktiskā farmakoloģija. Rīga: Zāļu infocentrs, 2011.

Del Águila-Carrasco A.J., Lara F., Bernal-Molina P., Riquelme-Nicolás R., Marin-Franch I., Esteve-Taboada J.J., Montés-Micó R., Kruger P.B., Lopez-Gil N. Effect of phenylephrine on static and dynamic accommodation. Journal of Optometry. 2019. № 12(1). Р. 30-37.

Esteve-Taboada J.J., Del Águila-Carrasco A.J., Bernal-Molina P., Ferrer-Blasco T., López-Gil N., Montés-Micó R. Effect of Phenylephrine on the Accommodative System. Journal of Ophthalmology. 2016. № 6. Article ID 7968918.

Grosvenor Т.Р. Primary Care Optometry. 5th ed. London: Butterworth-Heinemann Ltd, 2006.

Rosenfield M., Logan N. Optometry: Science, Techniques and Clinical Management. 2nd ed. London: Butterworth-Heinemann Ltd, 2009.

Yoo S.G., Cho M.J., Kim U.S., Baek S.-H. Cycloplegic Refraction in Hyperopic Children: Effectiveness of a 0.5 % Tropicamide and 0.5 % Phenylephrine Addition to 1 % Cyclopentolate Regimen. Korean Journal of Ophthalmology. 2017. № 31(3). Р. 249-256.

Tarasova N.A., Tarutta E.P., Markosian G.A., Maksimova M.V. Objective accommodation response value (completeness of cycloplegia) after diagnostic instillations of diverse medication. Russian Ophthalmological Journal. 2018. № 2. Р. 22-26.

Farhood Q.K. Cycloplegic Refraction in Children with Cyclopentolate versus Atropine. Journal of Clinical & Experimental Ophthalmology. 2012. № 3(7). Article № 1000239.

Sani R.Y., Hassan S., Habib S.G., Ifeanyichukwu E.P. Cycloplegic effect of atropine compared with cyclopentolate-tropicamide combination in children with hypermetropia. Nigerian Medical Journal. 2016. № 57(3). Р. 173-177.

Sherman A.E., Shaw M.M., Ralay-Ranaivo H., Rahmani B. Tropicamide has limited clinical effect on cycloplegia and mydriasis when combined with cyclopentolate and phenylephrine. Journal of AAPOS. 2019. № 23(1). Article No P30.E1-30.E5.

Laojaroenwanit S., Layanun V., Praneeprachachon P., Pukrushpan P. Time of maximum cycloplegia after instillation of cyclopentolate 1 % in children with brown irises. Clinical Ophthalmo­logy. 2016. № 10. Р. 897-902.

Kyei S., Nketsiah A.A., Asiedu K., Awuah A., Owusu-Ansah A. Onset and duration of cycloplegic action of 1 % cyclopentolate — 1 % tropicamide combination. African Health Sciences. 2017. № 17(3). Р. 923-932.

Rajeev A., Gupta G., Adhikari K.M., Yadav A.K., Sathyamoorthy M. Neurotoxic Effects of Topical Cyclopentolate. Medical Journal Armed Forces India. 2010. № 66(3). Р. 288-289.

Bartlett J.D. & Jaanus. Clinical Ocular Pharmacology. London: Butterworth-Heinemann Ltd, 2008.





Exchange of Experience